Table 1 Number of cervical cancer cases prevented compared to a no screening scenario
hrHPV prevalence | Number of cervical cancer cases prevented | |||||
|---|---|---|---|---|---|---|
Realistic uptake scenario | Optimal uptake scenario | |||||
hrHPV test + VIA | VIA + colposcopy | Ratio | hrHPV test + VIA | VIA + colposcopy | Ratio | |
2% | 7 | 2 | 3.50 | 237 | 172 | 1.38 |
4% | 13 | 7 | 1.86 | 443 | 336 | 1.32 |
6% | 15 | 10 | 1.50 | 627 | 469 | 1.34 |
8% | 19 | 17 | 1.12 | 809 | 593 | 1.36 |
10% | 20 | 20 | 1.00 | 991 | 743 | 1.33 |
12% | 23 | 21 | 1.10 | 1157 | 874 | 1.32 |
14% | 24 | 25 | 0.96 | 1319 | 996 | 1.32 |
16% | 28 | 25 | 1.12 | 1478 | 1118 | 1.32 |
18% | 31 | 29 | 1.07 | 1619 | 1210 | 1.34 |
20% | 32 | 30 | 1.07 | 1758 | 1302 | 1.35 |
22% | 37 | 28 | 1.32 | 1906 | 1409 | 1.35 |
24% | 41 | 29 | 1.41 | 2027 | 1493 | 1.36 |
26% | 42 | 30 | 1.40 | 2130 | 1573 | 1.35 |
28% | 44 | 31 | 1.42 | 2251 | 1654 | 1.36 |
30% | 46 | 34 | 1.35 | 2355 | 1723 | 1.37 |